InvestorsHub Logo

Blue Skys

06/08/22 12:07 PM

#3555 RE: TexasMarvL #3554

Just imagine what the stock price would be today if the neutralizing antibody test had been approved by the FDA. Nevertheless its as exciting as can be to be in at the birth of a new biotech with DED products in the deployment phase and a bunch of cancer related products on deck and the smart guys from Sapphire doing what they do creating new products. I'm forecasting an 8K on or before June 21 based on the 10Q.